

| Package | Price per Dose | Price | |
|---|---|---|---|
| 240 pills | C$2.41 | C$680.79 C$578.67 Free shipping | |
| 180 pills | C$2.45 | C$520.04 C$442.04 Free shipping | |
| 120 pills | C$2.49 | C$352.20 C$299.37 Free shipping | |
| 90 pills | C$2.61 | C$276.56 C$235.07 | |
| 60 pills | C$2.75 | C$193.82 C$164.75 | |
| 30 pills | C$2.93 | C$103.99 C$88.39 | |
| 10 pills | C$3.38 | C$40.16 C$34.14 | |
| 240 pills | C$2.75 | C$777.71 C$661.06 Free shipping | |
| 180 pills | C$2.79 | C$590.96 C$502.32 Free shipping | |
| 120 pills | C$2.95 | C$416.03 C$353.63 Free shipping | |
| 90 pills | C$3.09 | C$328.56 C$279.28 | |
| 60 pills | C$3.32 | C$234.01 C$198.91 | |
| 30 pills | C$3.60 | C$127.63 C$108.48 | |
| 10 pills | C$3.80 | C$44.89 C$38.16 |
Allegra is fexofenadine, a non-sedating antihistamine in the second‑generation H1 class, used to relieve symptoms of seasonal allergic rhinitis and chronic urticaria.
Active ingredient: fexofenadine. Drug class: second‑generation H1 antihistamines. The primary mechanism is the selective blocking of histamine at peripheral H1 receptors, which helps reduce allergy symptoms without causing significant sedation for most patients.
Allegra is formulated for oral administration and is available in tablet forms. In Canada, product availability and dosing forms may vary by retailer and provincial regulations, and some formulations may require guidance from a pharmacist or a prescriber depending on local rules.
Important concept: Allegra treats symptoms, not the underlying causes of allergy. It does not cure hay fever or hives, but it can lessen the intensity and frequency of symptoms when used as directed.
Allegra is indicated for relief of symptoms associated with allergic reactions mediated by histamine, notably in the airways and skin. The medication aims to minimize periods of discomfort caused by these conditions.
Seasonal allergic rhinitis (hay fever) commonly presents with sneezing, itchy nose, runny nose, nasal congestion, and itchy, watery eyes. Allegra may help reduce these symptoms and improve daily comfort during pollen seasons.
Perennial allergic rhinitis refers to year‑round nasal symptoms due to indoor or outdoor allergens. Allegra may provide ongoing relief for these symptoms when used as directed.
Chronic urticaria (hives) is an itchy skin condition characterized by red welts that appear at irregular intervals. Allegra may help lessen itching and the extent of welts in many patients with this condition.
Fexofenadine selectively binds to peripheral H1 receptors, blocking the action of histamine released during an allergic response. This reduces the scale of symptoms such as sneezing, itching, and nasal discharge.
Histamine is a chemical produced by the body during an allergic reaction. By occupying the H1 receptor sites, Allegra prevents histamine from triggering the symptoms that often accompany allergic conditions.
The second‑generation designation indicates a reduced tendency to cross into the central nervous system, which commonly translates to less daytime drowsiness compared with some older antihistamines. This pharmacologic profile supports daily functioning for many patients.
Allegra does not address the underlying cause of allergy and does not provide a cure for the condition. Symptom relief may vary between individuals, and continued use should be guided by clinical response and tolerance.
Dosage guidance depends on age, condition, and the specific product form. The label or a clinician should be consulted to determine the appropriate strength and dosing frequency for each individual case.
Adults and adolescents aged 12 years and older typically take Allegra as directed on the packaging or by a healthcare professional, with consideration given to any existing kidney impairment or other medical conditions. Do not exceed the recommended dose, and avoid double dosing if a dose is missed.
Take Allegra with a full glass of water. The absorption of fexofenadine can be reduced by fruit juice, particularly apple and orange juice, and should be separated from juice intake around the time of dosing. Food has variable effects on absorption, so follow the product labeling and pharmacist guidance; consistency in timing aids in maintaining stable blood levels.
Some formulations may be taken once daily or twice daily, depending on the designated strength and indication. When starting therapy, or when changing formulations, information from the official leaflet should be consulted, and a pharmacist can provide clarification on timing and food interactions.
For most patients, Allegra tablets should be swallowed whole; do not crush or chew unless the product labeling explicitly allows it. If there is difficulty swallowing, speak with a pharmacist or physician about alternative forms or dosing instructions.
Contraindications include a known hypersensitivity to fexofenadine or to any component of the product. A history of allergic reactions to related medications warrants caution and professional guidance before use.
Severe kidney impairment may influence drug clearance and dosing decisions. In such cases, medical advice is required to determine whether Allegra is appropriate and, if so, what adjustments are needed.
Pregnancy status and breastfeeding considerations require consultation with a healthcare professional to balance potential benefits and risks. If planning pregnancy or if pregnancy occurs during use, an assessment by a clinician is advised.
Children and adolescents should use Allegra only in age groups approved by the product labeling. Check the labeling for age‑related restrictions and obtain professional advice if uncertainty exists.
While generally well tolerated, Allegra may cause adverse effects in some individuals. It is important to monitor for any new or worsening symptoms and to seek medical advice if concerns arise.
Patients should use caution when operating heavy machinery or driving, particularly when first starting therapy, as rare cases of sedation or impaired alertness have been reported. If drowsiness occurs, assess personal tolerance before engaging in activities requiring full concentration.
Renal impairment may necessitate dosing adjustments and careful monitoring. Consult a healthcare professional if kidney function is believed to be compromised or if chronic kidney disease is present.
In elderly patients, sensitivity to adverse effects may be increased. A clinician may recommend closer monitoring during treatment initiation or when changing doses or formulations.
Potential drug interactions exist with certain foods and medications, as described in the interactions section. Always inform a pharmacist or clinician about all medicines and supplements being taken to avoid interactions that could affect Allegra's effectiveness or safety.
Common side effects reported by some patients include headache, dry mouth, and mild nausea. These events are usually transient and resolve with continued use or after dose adjustment, if applicable.
Less frequently, individuals may experience diarrhea, dizziness, or fatigue. A small number may notice sleepiness, although this is less common with second‑generation antihistamines compared with earlier agents.
Rash or other skin reactions can occur in rare cases. Any signs of an allergic reaction, such as swelling of the face, lips, tongue, or throat, or severe skin reactions, require urgent medical attention.
Splitting or discontinuing therapy should be discussed with a healthcare professional if side effects are persistent or intolerable. Seek medical advice if any symptoms worsen or new concerns arise during treatment.
Fruit juices, particularly apple and orange juice, can significantly reduce the absorption of fexofenadine. To maintain consistent therapeutic exposure, avoid taking Allegra with these juices or time the dose to occur well away from juice consumption.
Antacids containing aluminum or magnesium can also reduce absorption. If these products are required, separate their administration from Allegra by several hours, following professional guidance.
Certain concurrent medicines may alter Allegra levels or effects. Though not all interactions are clinically meaningful, consult a pharmacist before combining Allegra with other prescription or over‑the‑counter medications, including other antihistamines, sedatives, or herbal products.
Inform healthcare providers about all medicines and supplements being used, as interactions may influence treatment outcomes or safety. When in doubt, check the official patient information leaflet and seek professional guidance before starting new therapies.
Data on Allegra use during pregnancy are limited, and the decision to use this medication should involve a careful assessment of potential benefits to the mother and potential risks to the fetus. The lowest effective dose for the shortest duration is generally preferred if use is deemed necessary by a clinician.
Fexofenadine may pass into breast milk. If breastfeeding is being considered or is currently practiced, the risks and benefits should be discussed with a healthcare professional to determine the safest approach for both mother and infant.
Planning pregnancy or ongoing pregnancy requires consultation with a clinician. If pregnancy occurs while taking Allegra, seek medical advice promptly to reassess the treatment plan.
Relief is often noticed within about an hour for some symptoms, but onset can vary between individuals and specific conditions. If symptoms persist after several days of use, consult a healthcare professional for guidance.
Take the missed dose as soon as remembered, provided it is not near the next dose. If it is close to the time for the next dose, skip the missed dose and resume the regular schedule. Do not double the dose to make up for a missed one.
Allegra is generally non‑sedating, but combinations with alcohol or other sedative medicines may enhance drowsiness in some individuals. Exercise caution and avoid activities requiring full alertness if any impairment occurs.
Long‑term use may be appropriate for chronic allergy or urticaria symptoms when guided by a healthcare professional. Regular review of benefits and tolerance is advised to ensure ongoing suitability and safety.
Medication use in children is age‑dependent and must follow product labeling and clinician guidance. Seek a pediatrician or pharmacist's advice to determine an appropriate formulation and dose for younger patients.
Simultaneous use with other antihistamines is typically not recommended due to the risk of cumulative effects. Consult a healthcare professional before combining Allegra with other allergy therapies to establish a safe plan.
Kidney impairment may affect the clearance of fexofenadine. A clinician may adjust dosing or consider alternative therapies based on renal function and overall medical status.
Reference the official patient information leaflet supplied with the product and consult a pharmacist or physician for personalized guidance. Health Canada labeling and manufacturer resources provide authoritative details for product use and safety.
The official patient information leaflet accompanying the product contains specific dosing, contraindications, and interactions for Allegra. Review the document thoroughly before starting therapy and keep it for reference during treatment.
Consult a pharmacist or physician with any questions about Allegra, including suitability for a given medical history or pregnancy status. Healthcare professionals can tailor recommendations to individual needs and local regulatory requirements in Canada.
Provincial health resources and the Health Canada product monographs offer authoritative guidance on the use of Allegra within the Canadian healthcare system. In the event of a severe allergic reaction or other medical emergency, seek urgent medical help promptly.
14–21 days. Free from C$287.05 .
5–9 days. C$43.06
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
